Raphael Pharmaceutical Inc. ($RAPH) Insider Transactions

Last updated: 2026-03-14 10:18 UTC | Total transactions: 9

In the last 12 months, insiders at Raphael Pharmaceutical Inc. ($RAPH) filed 9 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.

Raphael Pharmaceutical Inc. operates in the Medicinal chemicals & botanical products industry (Life sciences sector).

Most Active Insiders

View all SEC Filings for Raphael Pharmaceutical Inc. (RAPH).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 10, 2025 Eliya Yehuda Director A Warrant to purchase Common Stock 200000 $0.00 200,000.0000 18,674,136 9999.99% 1.07%
May 12, 2022 Eliya Yehuda Director E Warrant to purchase Common Stock 202000 $0.00 0.0000 13,035,371 100.00% 1.55%
March 2, 2025 Pilo Shlomo Chief Executive Officer A Common Stock 200000 $0.50 3,983,701.0000 18,674,136 5.29% 1.07%
March 2, 2025 Pilo Shlomo Chief Executive Officer A Warrant to purchase Common Stock 100000 $0.00 1,100,000.0000 18,674,136 10.00% 0.54%
March 5, 2025 Dhadha Ajay Kumar Director A Common Stock 350000 $0.00 754,820.0000 18,674,136 86.46% 1.87%
March 5, 2025 Dhadha Ajay Kumar Director A Warrant to purchase Common Stock 250000 $0.00 250,000.0000 18,674,136 9999.99% 1.34%
Nov. 25, 2023 Eliya Yehuda Director A Common Stock 150000 $0.40 352,000.0000 16,444,399 74.26% 0.91%
Aug. 29, 2023 Louria Hayon Igal Chief Technology Officer X Common Stock 999000 $0.01 999,000.0000 16,109,514 9999.99% 6.20%
Aug. 29, 2023 Louria Hayon Igal Chief Technology Officer X Warrants to purchase Common Stock 999000 $0.00 0.0000 16,109,514 100.00% 6.20%